<?xml version="1.0" encoding="UTF-8"?>
<ref id="B136-antioxidants-09-00636">
 <label>136.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kotch</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Barrett</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Teachey</surname>
    <given-names>D.T.</given-names>
   </name>
  </person-group>
  <article-title>Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome</article-title>
  <source>Expert Rev. Clin. Immunol.</source>
  <year>2019</year>
  <volume>15</volume>
  <fpage>813</fpage>
  <lpage>822</lpage>
  <pub-id pub-id-type="doi">10.1080/1744666X.2019.1629904</pub-id>
  <pub-id pub-id-type="pmid">31219357</pub-id>
 </element-citation>
</ref>
